The CEO's Blind Spot Problem
Every CEO has a version of this problem: the information that reaches the top of the organization has been filtered, softened, or shaped by the people who gathered it. Performance reviews tell you what direct reports want you to know. Board reports tell you what looks defensible. Your own intuition tells you what you want to believe.
Strategic intelligence means having a clear, unfiltered view of where the business actually stands—across growth readiness, operational depth, valuation position, leadership capacity, and exit readiness. Not opinion. Not narrative. Scored outputs benchmarked against companies operating at comparable scale.
KCENAV's six diagnostic tools are built for exactly this purpose. Each one takes three minutes to complete and produces a scored output—not a consultant's presentation—that you can use immediately to identify where strategic attention is most needed.
What CEOs Find When They Run the Full Suite
Across the full KCENAV diagnostic suite, CEOs of $5M–$100M companies consistently find the same set of hidden exposures:
- Leadership concentration risk: The LEAD Score diagnostic consistently surfaces how much of the company's performance is tightly coupled to the CEO's personal involvement. This matters for scaling, capital raises, and exit—and it's rarely visible from inside the role.
- Valuation gaps the CEO doesn't own: The Valuation Optimizer often reveals that the largest EBITDA multiple gaps aren't in revenue growth—they're in financial reporting quality, management depth documentation, and customer concentration. These are fixable, but only if you know they exist.
- Growth readiness vs. growth ambition mismatch: CEOs frequently have growth targets that their operational infrastructure cannot support. The Growth Scaling diagnostic scores this gap objectively, giving the CEO a clear picture of what needs to be built before the growth initiative can succeed.
- HALO profile drift: As companies grow, the strategic asset quality that drove early success can erode without the CEO noticing—creeping customer concentration, technology currency gaps, or recurring revenue declining as a percentage. HALO Score tracks this across cycles.
The Diagnostics Most Relevant to CEOs
HALO Score
The CEO's strategic health index. Scores asset quality, disruption risk, growth readiness, and exit readiness in a single benchmarked output. Run quarterly as a standing measure of company health.
Run HALO Score →Leadership & Ops (LEAD)
Scores management depth, CEO dependency risk, decision-making infrastructure, and organizational capacity. Tells you whether the company can run without you—and what to build to make it true.
Run LEAD Score →Valuation Optimizer
Maps your current profile to EBITDA multiple benchmarks. Identifies the specific improvements that will move the multiple before you need it—whether for capital raise, partner buy-in, or eventual exit.
Run Valuation Optimizer →Growth Scaling
Scores the operational and structural readiness to support your growth targets. Identifies whether the bottleneck is capital, sales process, management capacity, or infrastructure.
Run Growth Scaling →